Glenmark’s heart failure treatment drug makes India debut
Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.
Drugs
Pharma
Drugs
Pharma
USFDA grants ātentative approvalā to Zydusā mental health drug
The USFDA has granted Zydus Lifesciences Limited ātentative approvalā to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in Japanļæ¼
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs
Health
Pharma
Decade-long study pinpoints baffling causes of epilepsy in children
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure.
Drugs
Pharma
California sues insulin makers, PBMs, for skyrocketing prices
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs
Health
Pharma
Own bacteria may cause some infections in hospitals: Study
If you are in a hospital, then at times, you get bacterial infections from one source ā yourself.
Drugs
Pharma
AstraZeneca to acquire US-based CinCor for $1.8 billion
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to aĀ statement.
Health
Medical
Pharma
Your age may say a lot about your cognitive health
A new artificial intelligence-driven model can analyse magnetic resonance imaging of brain scans to accurately capture cognitive decline linked to neurodegenerative diseases such.
Drugs
Pharma
Combined dish-and-chip technology to open ways to treat kidney disorder
US scientists have combined two technologies to show the effect of glucose in polycystic kidney disorder, a life-threatening genetic disorder, according to a.
Drugs
Pharma
FDA gives accelerated approval for Alzheimer’s drug
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to aĀ statement.